[
    [
        {
            "time": "",
            "original_text": "贝达药业：3项目进入Ⅲ期临床研究 肺癌抑制剂年底提交上市申请",
            "features": {
                "keywords": [
                    "贝达药业",
                    "肺癌抑制剂",
                    "Ⅲ期临床研究",
                    "上市申请"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "贝达药业：3项目进入Ⅲ期临床研究 肺癌抑制剂年底提交上市申请",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "广东大范围下调抗癌药价格 上市药企迎“以价换量”机会",
            "features": {
                "keywords": [
                    "广东",
                    "抗癌药价格",
                    "以价换量",
                    "上市药企"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "广东大范围下调抗癌药价格 上市药企迎“以价换量”机会",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]